Marjorie Labrecque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marjorie Labrecque has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adam MacDonald
Montreal Neurological Institute-Hospital, McGill University
1 shared publication - Jason Karamchandani
McGill University
1 shared publication - Jo Anne Stratton
Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada
1 shared publication - Laura K. Hamilton
Research Center of the University of Montreal Hospital (CRCHUM), Université de Montréal , Montreal, QC, H2X 0A9
1 shared publication - Lovatiana Andriamboavonjy
Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Montréal, Canada
1 shared publication - Marie-Noelle Boivin
The Neuro-Montreal Neurological Institute- Hospital, McGill University, Montreal, Québec, Canada
1 shared publication
Latest Publications
- Open Access
Comparative Analysis of Methods to Reduce Activation Signature Gene Expression in PBMCs
Summary: Preserving the in vivo cell transcriptome is essential for accurate profiling, yet factors during cell isolation including time ex vivo and temperature induce artifactual gene expression, particularly in stress-responsive immune cells. In this study, we investigated two methods to mitigate ex vivo activation signature gene (ASG) expression in peripheral blood mononuclear cells (PBMCs): transcription and translation inhibitors (TTis) and cold temperatures during isolation. Comparative analysis of PBMCs isolated with TTis revealed reduced ASG expression. However, TTi treatment impaired responsiveness to LPS stimulation in subsequent in vitro experiments. In contrast, cold isolation methods also prevented ASG expression; up to a point where the addition of TTis during cold isolation offered minimal additional advantage. These findings highlight the importance of considering the advantages and drawbacks of different isolation methods to ensure accurate interpretation of PBMC transcriptomic profiles. Highlights: Traditional room temperature isolation methods trigger activation signature gene expression in PBMCs, even when rapidly isolated, whereas 4°C isolation methods do not. Transcription and translation inhibitors and cold processing techniques reduce activation signature gene expression via shared mechanisms. PBMCs treated with transcription and translation inhibitors lose responsiveness to external stimuli. Cold isolation methods offer a suitable and inexpensive alternative to mitigate activation signature gene expression in PBMCs.
Open AccessComparative Analysis of Methods to Reduce Activation Signature Gene Expression in PBMCs
Summary: Preserving the in vivo cell transcriptome is essential for accurate profiling, yet factors during cell isolation including time ex vivo and temperature induce artifactual gene expression, particularly in stress-responsive immune cells. In this study, we investigated two methods to mitigate ex vivo activation signature gene (ASG) expression in peripheral blood mononuclear cells (PBMCs): transcription and translation inhibitors (TTis) and cold temperatures during isolation. Comparative analysis of PBMCs isolated with TTis revealed reduced ASG expression. However, TTi treatment impaired responsiveness to LPS stimulation in subsequent in vitro experiments. In contrast, cold isolation methods also prevented ASG expression; up to a point where the addition of TTis during cold isolation offered minimal additional advantage. These findings highlight the importance of considering the advantages and drawbacks of different isolation methods to ensure accurate interpretation of PBMC transcriptomic profiles. Highlights: Traditional room temperature isolation methods trigger activation signature gene expression in PBMCs, even when rapidly isolated, whereas 4°C isolation methods do not. Transcription and translation inhibitors and cold processing techniques reduce activation signature gene expression via shared mechanisms. PBMCs treated with transcription and translation inhibitors lose responsiveness to external stimuli. Cold isolation methods offer a suitable and inexpensive alternative to mitigate activation signature gene expression in PBMCs.